Cargando…

Treatment of Acquired von Willebrand Disease due to Extracorporeal Membrane Oxygenation in a Pediatric COVID-19 Patient with Vonicog Alfa: A Case Report and Literature Review

Acquired von Willebrand disease (aVWD) is frequently observed in patients with the need for extracorporeal membrane oxygenation (ECMO). aVWD can be treated by plasma-derived concentrates containing factor VIII (FVIII) and/or von Willebrand factor (VWF) and recombinant VWF concentrate as well as adju...

Descripción completa

Detalles Bibliográficos
Autores principales: Heubner, Lars, Trautmann-Grill, Karolin, Tiebel, Oliver, Mirus, Martin, Güldner, Andreas, Rand, Axel, Spieth, Peter Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949976/
https://www.ncbi.nlm.nih.gov/pubmed/36846831
http://dx.doi.org/10.1055/a-2008-4367